My Gene Counsel
  • Labs & Precision Medicine
  • Health Systems & Clinical Partners
  • BIOPHARMA, CLINICAL TRIALS & PAYERS
  • Solutions
    • My Gene Screen
    • Living Lab Reports
    • Genetic Alerts
  • Media
    • Genetic Journal
    • News
    • Press Releases
    • Multimedia
    • Publications
    • Career Resources
    • Case Series
  • About Us
  • Login
Select Page
VUS Reclassified to Suspected Deleterious: When Genetic Counseling Updates Become Lifesaving

VUS Reclassified to Suspected Deleterious: When Genetic Counseling Updates Become Lifesaving

by Danielle Bonadies | Nov 30, 2017 | Genetic Journal

Mary Ellen always knew that her family history included cancer. Her mom was diagnosed with breast cancer in her 50s and died in her 60s. Early-onset breast cancer, prostate cancer, and possible ovarian cancers were seen in aunts, uncles, and cousins. So, it was not...

Recent Posts

  • Genetic Testing Challenges in Precision Medicine: Lab Fails to Report NF2 Mosaic Variant
  • Career Compass: Tips and Tricks for Second Year Students and Recent Graduates with Christina Frater
  • Continuing Education Opportunities
  • ABGC Boards Resources
  • The Speed and Scope of Genetic Updates | My Gene Counsel

Archives

  • About Us
  • Media
  • Genetic Journal Blog
  • Labs & Precision Medicine
  • Health Systems & Clinical Partners
  • Biopharma, Clinical Trials & Payers
  • My Gene Screen
  • Living Lab Reports®
  • Genetic Alerts
  • Contact Us
  • FAQs
  • Career Resources

The My Gene Counsel portal and website should not be construed, directly or indirectly, as the practice of medicine or dispensing of medical services by My Gene Counsel or its Partners.

My Gene Counsel   ©